Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
To the Editor In a recent edition of Heart, Potier et al reported the results of a large, observational analysis of the REACH registry.1 The authors sought to retrospectively compare clinical outcomes in angiotensin receptor blocker (ARB) and ACE inhibitor (ACEi) treated patients, using propensity score matching to reduce confounding by indication. They conclude that treatment with ARB was more effective than with ACEi, across a wide spectrum of cardiovascular diseases and with regard to a number of different clinical outcomes. However, we …
Competing interests ASH has received speaker honoraria from Servier.
Provenance and peer review Not commissioned; internally peer reviewed.